首页   >  
Apoptosis Pathway
  >  
Bcl2

所有产品分类

所有产品

信号通路

研究领域

天然产物

抗体

多肽

催化剂

杂质对照品

医药中间体

基础原料

Bcl2

结构式 货号 产品名称 CAS号
BCL6-IN-3 结构式
BCP49128 BCL6-IN-3 2253878-44-1
BCL6-IN-3 is a potent BCL6 degrader.
Pyridoclax 结构式
BCP23863 Pyridoclax 1651890-44-6
Pyridoclax is a potential Mcl-1 inhibitor.
AVN-944 结构式
BCP23877 AVN-944 297730-17-7
AVN944 is a biotech drug that demonstrated a statistically meaningful impact on IMPDH and other proteins that are critical to activities in cancer cells, including nucleotide biosynthesis, energy and metabolism, DNA replication, apoptosis and cell cycle control. AVN944 has been associated with cancer cell death in clinical trials. It is being investigated for the treatment of patients with advanced hematologic malignancies.
(R)-MIK665 结构式
BCP47788 (R)-MIK665 1799831-02-9
(R)-MIK665 is the less active enantiomer of MIK665. MIK665 is a special Mcl-1 inhibitor with an IC50 of 1.81 nM.
Lisaftoclax 结构式
BCP47569 Lisaftoclax 2180923-05-9
Lisaftoclax exhibits IC50 values of 5.5 nM and 6.4 nM in Bcl-2 dependent RS4;11 cells and Bcl-xl dependent Molm13 cells.
SMBA1 结构式
BCP45276 SMBA1 906440-37-7
SMBA1 is a selective acrivator of Bax, a central death regulator. It acts by potently suppressing lung tumour growth via apoptosis.
BI-3802 结构式
BCP41514 BI-3802 2166387-65-9 
BI-3802 is a BCL6 inhibitor, with an IC50 of ≤3 nM. BI-3802 shows an IC50 of 43 nM for the cellular BCL6.
Mcl1-IN-2 结构式
BCP40301 Mcl1-IN-2 292057-76-2
Mcl1-IN-2, a hydroxyquinoline derivative, is an Mcl-1 inhibitor.
APG-2575 结构式
BCP40069 APG-2575 APG2575
APG-2575 is a novel, orally administered small-molecule Bcl-2‒selective inhibitor.
BDA-366 结构式
BCP39785 BDA-366 1909226-00-1
BDA-366 is a small-molecule Bcl2-BH4 domain antagonist, BDA-366, that binds BH4 with high affinity and selectivity.
123下一页末页共 56 条记录 1 / 6 页 
2853530910